S2 Genomics Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
19
- Latest Deal Type
-
M&A
S2 Genomics General Information
Description
Developer of a spatial sequencing technology designed to provide products that process raw tissues into samples ready for genomic analyses. The company's technology automates the preparation of single cells or nuclei suspensions from solid tissue samples, which permits researchers to isolate rapidly and reproducibly and minimal impact on the cellular transcriptome, enabling clinicians to optimize both the quantity and quality of viable cells or nuclei isolated from a variety of tissue types.
Contact Information
Website
www.s2genomics.com(Operating Subsidiary)
Corporate Office
- 6712 Preston Avenue
- Suite D
- Livermore, CA 94551
- United States
Corporate Office
- 6712 Preston Avenue
- Suite D
- Livermore, CA 94551
- United States
S2 Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 17-Sep-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A) | 23-Jan-2024 | Completed | Generating Revenue | |||
| 5. Debt - General | 01-Jan-2022 | Completed | Generating Revenue | |||
| 4. Angel (individual) | 06-Jul-2021 | Completed | Generating Revenue | |||
| 3. Seed Round | 11-Dec-2019 | Completed | Generating Revenue | |||
| 2. Grant | 26-Jun-2018 | $280K | Completed | Generating Revenue | ||
| 1. Grant | 13-Jun-2018 | $20.6M | Completed | Generating Revenue |
S2 Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-1 | ||||||||
| Seed |
S2 Genomics Patents
S2 Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025179189-A1 | System and method for tissue analysis | Pending | 21-Feb-2024 | ||
| WO-2024073453-A2 | Tissue processing cartridge and instrument | Inactive | 26-Sep-2022 | ||
| WO-2024073453-A3 | Tissue processing cartridge and instrument | Inactive | 26-Sep-2022 | ||
| EP-4487100-A2 | Method and apparatus for processing tissue samples | Pending | 02-Mar-2022 | ||
| EP-4487100-A4 | Method and apparatus for processing tissue samples | Pending | 02-Mar-2022 | C12N15/1065 |
S2 Genomics Signals
S2 Genomics Former Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BroadOak Capital Partners | Growth/Expansion | Minority | ||
| Cambrian Growth Partners | Growth/Expansion | Minority | ||
| GCAIA Capital | Angel Group | |||
| HealthTech Capital | Angel Group | Minority | ||
| Life Science Angels | Angel Group | Minority |
S2 Genomics FAQs
-
When was S2 Genomics founded?
S2 Genomics was founded in 2016.
-
Where is S2 Genomics headquartered?
S2 Genomics is headquartered in Livermore, CA.
-
What is the size of S2 Genomics?
S2 Genomics has 19 total employees.
-
What industry is S2 Genomics in?
S2 Genomics’s primary industry is Other Devices and Supplies.
-
Is S2 Genomics a private or public company?
S2 Genomics is a Private company.
-
What is S2 Genomics’s current revenue?
The current revenue for S2 Genomics is .
-
How much funding has S2 Genomics raised over time?
S2 Genomics has raised $18.4M.
-
Who are S2 Genomics’s investors?
BroadOak Capital Partners, Cambrian Growth Partners, GCAIA Capital, HealthTech Capital, and Life Science Angels are 5 of 13 investors who have invested in S2 Genomics.
-
When was S2 Genomics acquired?
S2 Genomics was acquired on 17-Sep-2025.
-
Who acquired S2 Genomics?
S2 Genomics was acquired by Precision Cell Systems.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process